New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 6, 2014
13:25 EDTJNJ, JNJ, SNN, SNN, SYK, SYK, ZMH, ZMHLeerink's medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Newitter provides his perspective on new products, technologies and key focus topics and issues to be covered at the upcoming American Academy of Orthopedic Surgeons (AAOS) 2014 Conference in New Orleans on March 11-15 on an Analyst/Industry conference call to be held on March 6 at 2 pm.
News For JNJ;SNN;SYK;ZMH From The Last 14 Days
Check below for free stories on JNJ;SNN;SYK;ZMH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
17:42 EDTJNJJ&J begins sales process for its medical device unit Cordis, WSJ says
Subscribe for More Information
August 25, 2014
08:27 EDTJNJJanssen Affiliate Cilag acquires Covagen, terms not disclosed
Subscribe for More Information
07:03 EDTJNJVIVUS acquires patents from Janssen Pharmaceuticals
VIVUS (VVUS) announced the acquisition of a group of patents from Janssen Pharmaceuticals (JNJ) covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. Janssen has agreed to dismiss the lawsuit it brought against VIVUS on August 22, 2014 in the U.S. District Court for the District of Delaware. VIVUS will pay a one-time upfront fee and a royalty to Janssen on Qsymia product sales for an assignment of these topiramate-related patents owned by Janssen. VIVUS has an option to buy out the royalty for a predetermined amount.
August 21, 2014
05:42 EDTJNJIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 18, 2014
11:41 EDTJNJCubist rises after report sparks takeover interest speculation
Subscribe for More Information
10:47 EDTZMHZimmer advances following analyst upgrade
Subscribe for More Information
10:01 EDTZMHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Achillion (ACHN) upgraded to Buy from Hold at Deutsche Bank... CNOOC (CEO) upgraded to Neutral from Underperform at Credit Suisse... Dollar General (DG) upgraded to Buy from Neutral at Sterne Agee... Equity Residential (EQR) upgraded to Hold from Underperform at Jefferies... HMS Holdings (HMSY) upgraded to Overweight from Equal Weight at First Analysis... HP (HPQ) upgraded to Buy from Neutral at Monness Crespi... Halcon Resources (HK) upgraded to Buy from Hold at MLV & Co.... KapStone (KS) upgraded to Buy from Hold at Deutsche Bank... Sportsman's Warehouse (SPWH) upgraded at RW Baird... Westlake Chemical (WLK) upgraded to Neutral from Reduce at SunTrust... WisdomTree (WETF) upgraded to Neutral from Sell at Citigroup... Zimmer (ZMH) upgraded to Outperform from Market Perform at William Blair.
07:04 EDTZMHZimmer upgraded to Outperform from Market Perform at William Blair
William Blair upgraded Zimmer Holdings to Outperform citing the recent pullback in shares and its belief the proposed Biomet acquisition will close.
August 15, 2014
10:01 EDTSNNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Apollo Global (APO) downgraded to Market Perform from Outperform at Wells Fargo... Calavo Growers (CVGW) downgraded to Neutral from Outperform at Wedbush... DaVita (DVA) downgraded to Hold from Buy at Deutsche Bank... Dangdang (DANG) downgraded to Neutral from Outperform at Credit Suisse... Ducommun (DCO) downgraded to Neutral from Buy at DA Davidson... Energy XXI (EXXI) downgraded to Sector Perform from Outperform at Howard Weil... Fifth Street Finance (FSC) downgraded to Neutral from Buy at Gilford Securities... Genetic Technologies (GENE) downgraded to Neutral from Buy at Ladenburg... Harmony Gold (HMY) downgraded to Underweight from Neutral at HSBC... Ignite Restaurant (IRG) downgraded to Neutral from Overweight at Piper Jaffray... JDSU (JDSU) downgraded to Hold from Buy at Argus... K12 (LRN) downgraded to Market Perform from Outperform at Wells Fargo... KKR (KKR) downgraded to Market Perform from Outperform at Wells Fargo... Lexington Realty (LXP) downgraded to Neutral from Buy at Ladenburg... Lithia Motors (LAD) downgraded to Underweight from Equal Weight at Morgan Stanley... New York & Co. (NWY) downgraded to Neutral from Buy at Janney Capital... OCI Partners (OCIP) downgraded to Underweight from Equal Weight at Barclays... OmniVision (OVTI) downgraded to Neutral from Outperform at RW Baird... Smith & Nephew (SNN) downgraded to Equal Weight from Overweight at Morgan Stanley... Subsea 7 (SUBCY) downgraded to Neutral from Buy at Goldman... Tencent (TCEHY) downgraded to Neutral from Overweight at JPMorgan... ViaSat (VSAT) downgraded to Equal Weight from Overweight at Stephens... bebe stores (BEBE) downgraded to Neutral from Buy at Janney Capital.
09:10 EDTSNNSmith & Nephew downgraded to Equal Weight from Overweight at Morgan Stanley

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use